Skip to main content

Advertisement

Table 2 Proportion of patients receiving each of the 17 most common first antibiotic regimens

From: Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study

  Overall Cellulitis and
Gangrene
Cellulitis and
Osteomyelitis
Cellulitis and
Ulcer
Cellulitis Only
  (n = 2248) (n = 894) (n = 503) (n = 644) (n = 207)
  Observed Proportion (Range*) %
Piperacillin-tazobactam 16.4 (22.8) 20.1 (23.9) 14.7 (24.2) 14.9 (14.2) 8.7 (11.5)
Piperacillin-tazobactam, Vancomycin 15.7 (36.1) 16.1 (33.9) 18.1 (58.3) 15.4 (21.8) 9.7 (11.3)
Ampicillin-sulbactam 10.8 (50.5) 11.3 (42.5) 10.7 (48.8) 9.5 (30.7) 12.6 (21.4)
Vancomycin 6.9 (13.5) 6.2 (6.1) 9.1 (21.1) 5.7 (7.0) 7.7 (13.8)
Cefazolin 4.2 (12.6) 3.4 (9.2) 3.2 (19.7) 5.6 (14.4) 6.3 (12.1)
Amoxicillin-clavulanate§ 2.0 (3.3) 1.5 (4.1) 0.6 (10.9) 3.7 (7.3) 2.4 ( - )
Ticarcillin-clavulanate 2.0 (48.6) 1.9 (41.6) 1.6 (40.6) 2.5 (43.1) 1.9 ( - )
Cephalexin§ 1.6 (7.3) 0.8 (4.6) 0.8 (26.2) 2.2 (10.1) 4.8 (12.7)
Ertapenem 1.4 (14.9) 1.0 (11.5) 2.6 (19.9) 0.5 (12.1) 1.0 ( - )
Ciprofloxacin§ 1.3 (2.5) 1.2 (6.1) 1.4 (6.1) 1.6 (7.9) 0.5 ( - )
Ampicillin-sulbactam, vancomycin 1.2 (3.0) 1.2 (2.7) 1.4 (17.4) 1.1 (3.7) 1.0 ( - )
Imipenem 1.2 (4.3) 2.1 (11.5) 0.8 (24.9) 0.3 ( - ) 1.0 ( - )
Ceftriaxone 1.2 (3.8) 0.8 (3.7) 1.4 (6.2) 1.6 (6.9) 1.0 ( - )
Ciprofloxacin, clindamycin 1.1 (12.7) 1.5 (21.1) 0.6 (15.6) 0.8 (2.9) 1.4 ( - )
Clindamycin 1.1 (3.6) 1.1 (7.2) 0.8 (9.7) 0.8 (10.8) 2.4 ( - )
Gatifloxacin§ 1.1 (4.1) 0.4 (8.1) 1.2 (3.9) 1.9 (23.7) 1.0 ( - )
Nafcillin 1.1 (2.8) 0.6 (6.5) 1.4 (7.9) 1.1 (25.1) 2.4 ( - )
  1. * Statistic uses shrunken hospital rates (see methods)
  2. § Given orally
  3. ( - ) No range